跳至主要内容
临床试验/DRKS00019048
DRKS00019048尚未招募未知

Open-Label Placebo Application in Addition to Standard Therapy in order to increase therapeutic Benefits during Treatment of adolescents with Major Depression - OLP-Pilot

niversitätsklinikum Essen0 个研究点目标入组 40 人开始时间: 2019年11月14日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
16 Years 至 18 Years(—)
性别
All

入选标准

  • Major depression; diagnosis according to DSM-5, ascertained by a board certified child and adolescent psychiatrist or psychotherapist by means of a semi-structured diagnostic interview (Kinder-DIPS-Open-Access; parent and child/adolescent version; Margraf et al., 2017)
  • Informed consent from parents and patient

排除标准

  • Any of the following co-morbide (actual or life-time) mental disorders: eating disorder, schizophrenia, manic episode(s)
  • Actual somatic or neurologic disease incuding epilepsia
  • Inability to comprehend or speak German
  • Current treatment with antidepressants
  • Known lactose intolerance
  • Known allergies against other components of the placebo pills (Lactose-monohydrate, cellulose powder, magnesiumstearat (Ph. Eur.), and microcrystalline cellulose)

研究者

发起方
niversitätsklinikum Essen

相似试验

Open-Label Placebo Application in Addition to... | 临床试验